Correlation Between Hansa Biopharma and Saniona AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hansa Biopharma and Saniona AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hansa Biopharma and Saniona AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hansa Biopharma AB and Saniona AB, you can compare the effects of market volatilities on Hansa Biopharma and Saniona AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hansa Biopharma with a short position of Saniona AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hansa Biopharma and Saniona AB.

Diversification Opportunities for Hansa Biopharma and Saniona AB

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Hansa and Saniona is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Hansa Biopharma AB and Saniona AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Saniona AB and Hansa Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hansa Biopharma AB are associated (or correlated) with Saniona AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Saniona AB has no effect on the direction of Hansa Biopharma i.e., Hansa Biopharma and Saniona AB go up and down completely randomly.

Pair Corralation between Hansa Biopharma and Saniona AB

Assuming the 90 days trading horizon Hansa Biopharma AB is expected to under-perform the Saniona AB. But the stock apears to be less risky and, when comparing its historical volatility, Hansa Biopharma AB is 3.5 times less risky than Saniona AB. The stock trades about -0.27 of its potential returns per unit of risk. The Saniona AB is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest  411.00  in Saniona AB on August 29, 2024 and sell it today you would lose (101.00) from holding Saniona AB or give up 24.57% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Hansa Biopharma AB  vs.  Saniona AB

 Performance 
       Timeline  
Hansa Biopharma AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hansa Biopharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Saniona AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Saniona AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Hansa Biopharma and Saniona AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hansa Biopharma and Saniona AB

The main advantage of trading using opposite Hansa Biopharma and Saniona AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hansa Biopharma position performs unexpectedly, Saniona AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Saniona AB will offset losses from the drop in Saniona AB's long position.
The idea behind Hansa Biopharma AB and Saniona AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals